Clinical Trial Update: Prevention of Post-ERCP Pancreatitis by Indomethacin vs Diclofenac [NA]

View source ↗

Summary

A clinical trial comparing indomethacin versus diclofenac for preventing post-ERCP pancreatitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ercp Pancreatitis

Drugs mentioned

• Diclofenac (diclofenac)
• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Post-ERCP Acute Pancreatitis, NSAIDs | NA | Status: TERMINATED